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Abstract
Background/Aim.  Heterotopic ossification (HO) is an
important complication of head and spinal cord injuries
(SCI). Pulse low-intensity electromagnetic field (PLIMF)
therapy increases blood flow to an area of pain or inflam-
mation, bringing more oxygen to that area and helps to re-
move toxic substances. The aim of this study was to deter-
mine the effect of PLIMF as prophylaxis of HO in patients
with SCI. Methods. This prospective random control clini-
cal study included 29 patients with traumatic SCI. The pa-
tients were randomly divided into experimental (n = 14) and
control group (n  =  15). The patients in the experimental
group, besides exercise and range of motion therapy, were
treated by PLIMF of the following characteristics: induction
of 10 mT, frequency of 25 Hz and duration of 30 min.
Pulse low-intensity electromagnetic field therapy started in
the 7th week after the injury and lasted 4 weeks. The pres-
ence or absence of HO around the patients hips we checked
by a plane radiography and Brookers classification. Func-
tional capabilities and motor impairment were checked by
Functional Independent Measure (FIM), Barthel index and
American Spinal Injury Association (ASIA) impairment
class. Statistic analysis included Kolmogorov-Smirnov test,
Shapiro-Wilk test, Mann Whitney Exact test, Exact Wil-
coxon signed rank test and Fischer Exact test. Statistical
significance was set up to p < 0.05. Results. At the end of
the treatment no patient from the experimental group had
HO. In the control group, five patients (33.3%) had HO. At
the end of the treatment the majority of the patients from
the experimental group (57.14%) moved from ASIA-A to
ASIA-B class. Conclusion. Pulse low-intensity electromag-
netic field therapy could help as prophylaxis of HO in pa-
tients with traumatic SCI.
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Apstrakt
Uvod/Cilj. Heterotopska osifikacija (HO) glavna je
komplikacija povrede glave i kičmene moždine (spinal
cord injury  − SCI). Terapija primenom pulsnog elektro-
magnetnog polja niskog intenziteta (pulse low-intensity
electromagnetic field − PLIMF) ubrzava protok krvi u zoni
bola ili upale, dovodeći više kiseonika u tu zonu i poma-
žući u uklanjanju toksičnih materija. Cilj ove studije bio
je da se odrede efekti primene PLIMF u prevenciji HO
kod bolesnika sa SCI. Metode.  U ovu prospektivnu
randomiziranu kliničku studiju bilo je uključeno 29 bole-
snika sa trauamatskim SCI. Bolesnici su randomizirani u
eksperimentalnu (n = 14) i kontrolnu (n = 15) grupu.
Bolesnici iz eksperimentalne grupe, osim vežbi i terapije
kretanjem, bili su podvrgnuti terapiji PLIMF indukcije
10 mT, frekvencije 25 Hz u trajanju od 30 min. Primena
PLIMF počela je u sedmoj nedelji od povrede i trajala je
četiri nedelje. Prisustvo ili odsustvo HO oko kukova
bolesnika proveravano je radiografskim snimkom i Bro-
okersovom klasifikacijom. Funkcionalne mogućnosti i
oštećenje motorike proveravni su primenom Functional
Independent Measure (FIM), Barthel indeks i klasom ošteće-
nja prema American Spinal Injury Association (ASIA). Stati-
stička analiza vršena je testovima Kolmogorov-Smirnov,
Shapiro-Wilk, Mann-Whitney Exact, Exact Wilcoxon Signed
Rank i Fischer Exact. Statistička značajnost bila je do vre-
dnosti p < 0,05. Rezultati. Na kraju lečenja nijedan bo-
lesnik iz eksperimentalne grupe nije imao HO. U kon-
trolnoj grupi pet bolesnika (33,3%) imalo je HO. Na
kraju lečenja većina bolesnika eksperimentalne grupe
(57,14%) prešla je iz klase ASIA-A u ASIA-B. Zaklju-
čak. Primena PLIMF pomaže u profilaksi HO kod bole-
snika sa traumatskim SCI.
Ključne reči:
kičmena moždina, povrede; osifikacija, patološka;
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Introduction
Heterotopic ossification (HO) is an important complica-
tion of head and spinal cord injuries (SCI). Heterotopic ossifi-
cation produces metaplastic formation of new bone in connec-
tive tissues and muscles surrounding joints
 1, 2. In patients with
SCI, HO is usually found in muscles below the level of injury.
In adult patients with SCI, the incidence of HO is approxi-
mately from 11 to 75% 
1−5. The onset of HO, regardless of its
origin, ranges from 4−12 weeks. A peak occurrence is at 2
months after the head trauma, SCI or specific insult
 6. The re-
habilitation process of patients with SCI is disturbed by the
presence of HO. Approximately one third of SCI patients de-
velop restricted hip motion or ankylosis, more frequently in
patients with cervical than thoracic and lumbar injuries 
3. Be-
cause of that, they need more time for a successful rehabilita-
tion, which is also more expensive. Fiedler et al. 
8 found that $
2 million were spent because of medical complications in
postacute stage of the 115 persons with SCI. Medicaments,
range of motion (ROM) and exercise therapy and radiation
therapy are used for prophylaxis of HO formation
 2, 4, 5, 9, 10. The
treatment of HO consists of ROM and exercise, medicaments,
radiation therapy and surgery 
2, 4, 5, 9, 11.
Magnets and electromagnetic fields have been used for a
long time in clinical medicine. Electromagnetic fields can be
static or pulse
 12. It has been estimated that $ 500 million is
spent on magnetic devices annually in the United States and
Canada
 13. Several brands of static magnets are currently avail-
able on the market: such as magnetic necklaces or magnetic
insoles
 13, 14. A dosage of static magnets implies the strength of
magnetic fields and length of the magnetic procedure. Elec-
tromagnetic fields therapy mostly means pulse low-intensity
electromagnetic field (PLIMF) therapy
 12, 15. A dosage of
PLIMF implies induction around the inductor, frequency of
the field, length of the procedure and number of the proce-
dures. Magnets appear to increase blood flow to an area of
pain or inflammation, bringing more oxygen to the area and
removing toxic substances. Magnets seem to affect positive
and negative charges of sodium and potassium ions within the
membranes around blood vessels and nerves and to relax small
smooth muscle valves in the capillaries
 16. The results of the
experimental investigations demonstrate possibilities of
PLIMF in the treatment of damaged parts of the spinal cord
 17.
There are different opinions in the review literature
about HO in patients with SCI. Beside the fact that in the
classic rehabilitation textbooks HO is discussed as an im-
portant complication of SCI, this complication was not re-
ported in some professional reports
 4, 11, 18−20. In the large data
review from the American National SCI Center, in patients
who had injuries between 1973 and 1998, McKinley et al.
 21
did not find HO as long-term medical complication. Many
authors consider a radiation therapy as indivisible part of HO
prophylaxis
 4, 5, 9−11. McKinley et al.
 21, however, explicitly
claim that only biphosphonates may prevent tissue ossifica-
tion. The role of physical therapy in the treatment of patients
after SCI is still controversial. Functional electrical stimula-
tion (FES) is used for motor skill improvement in a late stage
of rehabilitation
 18. Triceps surae electrical stimulation re-
duces spasticity in the patients after SCI
 22. Exercise is the first
line in prophylaxis or treatment of HO. Unfortunately exercise
has little or no direct effect on blood volume or hemoglobin
content
 23. Investigators believe that ROM activity provided by
physical therapy and occupational therapy can minimize the
risk of joint ankylosis without promoting HO
 4, 6, 11. On the
other hand, there are authors who have experimentally estab-
lished that forcible manipulation induced heterotopic bone
formation
 5. Serial casting and dynamic splinting are used to
maintain joint motion in the presence of HO
 24. There is no
evidence about efficiency of these treatments. Miller et al.
 25
speak about good treatment effect of iontophoresis with dexa-
methasone in patients with myositis ossificans. In the available
literature we have not found anything about the use and effi-
ciency of magnetic fields in the prophylaxis of HO. Etiology
of HO is not yet known. Decreased blood flow and changes in
pH may be important
 1. Taking into consideration a well
proved influence of magnetic fields on blood flow, circulation
and inflammation, we presume that magnetic fields could be
useful in prophylaxis of HO
 12, 15−17, 26, 27. The aim of this study
was to determine the effect of PLIMF as prophylaxis of HO in
patients with traumatic SCI.
Methods
We performed a prospective random control clinical
study. The patients were recruited from the Neurosurgery
Clinic and Clinic for Physical Medicine and Rehabilitation,
Military Medical Academy, Belgrade. To be eligible, they
had to be between 18 and 45 years of age, have completeness
or incompleteness traumatic SCI, have no HO in 2 months
after SCI, have no other prominent complications in acute
stage of rehabilitation, were not taking medications which in-
fluence HO, have no any contraindications for the treatment
by the PLIMF
 5, 12. Patients were excluded if they had pres-
sure ulcer or severe spasticity because of these conditions are
positively related to the formation of HO
 4.
The study protocol consisted of determining demo-
graphic characteristics of patients, some biochemistry pa-
rameters (erythrocyte sedimentation rate − ESR, serum cal-
cium − Ca, serum alkaline phosphatase − ALP), functional
capabilities of patients defined by the Functional Independ-
ent Measure (FIM) and the Barthel index, neurological defi-
cit defined by the American Spinal Injury Association
(ASIA), and presence or absence of HO around patients hips
toward Brookers classification
 2, 5, 7, 28. The study protocol
was approved by the local ethic committee. All the patients
gave the written consent before participating in the study.
The patients who met inclusion criteria were randomly
divided into the experimental and control group. They
started with ROM and exercise therapy in both groups as
soon as they achieved their vital steady state. The patients
in the experimental group, besides ROM and exercise ther-
apy, were treated by PLIMF. This treatment started on the
average in seventh week after the injury. The treatment by
PLIMF lasted four weeks and was performed by the use of
an apparatus “Magnemed MT-91, Electromedicina Nis”.
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(Figure 1). A dosage of PLIMF implied: induction of 10
mT (miliTesla), frequency of 25 Hz and duration of 30 min. We
performed this therapy five times a week. We checked the pres-
ence and grade or absence of HO at the start and the end of the
treatment. The plain radiographies were red by the same radiolo-
gist. Functional capabilities of the patients were checked by the
same physiotherapist at the start and the end of the treatment.
Statistic analysis included Kolmogorov-Smirnov test,
Shapiro-Wilk test, Mann Whitney Exact test, Exact Wil-
coxon signed rank test and Fischer's Exact test. Statistical
significance was set up to p < 0.05. The data was assessed by
SPSS version 10.0 for Windows.
Results
A total of 33 patients were recruited by a rehabilitation
specialist, neurosurgical specialist and physiotherapist. Out
of them three refused to participate. Thirty patients were ran-
domized. One patient from the experimental group was
withdrawn because of the lack of protocol compliance. A
total of 29 patients participated in the study. The groups were
homogeneous in terms of age and sex of the patients. The
majority of the patients in the experimental group (50%) had
cervical level of SCI; the majority of the patients in the con-
trol group (53.3%) had thoracic level of SCI (Table 1).
There was no significant difference between the groups
in terms of functional capabilities: at the end of the treat-
ment, the patients of both groups achieved a significant
functional improvement (Table 2).
There were significant differences between the groups
in terms of ASIA impairment class. At the end of the treat-
ment the majority of the patients from the experimental
group (57.14%) moved from the ASIA-A to the ASIA-B
class; at the end of the treatment the majority of the patients
from the control group (60%) remained in the ASIA-A class
(Table 3).
Fig. 1 − A patient during the treatment with pulse low-intensity electromagnetic field
(PLIMF) (“Magnemed MT-91, Electromedicina Nis”)
Table 1
Characteristics of the patients
Patients characteristics Experimental group (n = 14)
ґ ± SD
Control group (n = 15)
ґ ± SD p
Mean age (years), ґ ± SD 30.57 ± 11.97 31.47 ± 10.78 0.64*
Sex [n (%)]
male
female
14 (100)
0 (0)
14 (93.3)
1 (6.67)
1.0 
†
Start of magnetotherapy (week), ґ ± SD 7.43 ± 3.25
Duration of magnetotherapy (week), ґ ± SD 4.21 ± 0.58
Level of spinal cord injury [n (%)]
cervical
thoracic
lumbosacral
cervical-thoracic
thoracic-lumbosacral
7 (50)
4 (28.5)
1 (7.14)
1 (7.14)
1 (7.14)
2 (13.3)
8 (53.3)
1 (6.60)
2 (13.3)
2 (13.3)
* Analysis conducted using Mann Whitney Exact Test
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There were significant differences between the groups in
terms of the presence of HO at the end of the treatment. In the
experimental group, no one had HO. In the control group, five
patients (33.3%) had several grades of HO (Table 4). These
HO were mostly in the Brooker classes I and II (Figure 2).
Fig. 2 − A patient with Brooker class I/II
Discussion
This study showed that the patients with traumatic SCI,
who were treated by PLIMF, had no HO at the end of the
treatment. On the other hand, 33.33% of the patients who
were not treated by the PLIMF had HO around their hips. In-
flammation was significantly diminished by PLIMF treat-
ment. The majority of patients who were treated by PLIMF
moved into the better ASIA class. These results could be ex-
plained by the biological effect of magnetic field. Patho-
physiology of HO is not clear. Important contributing factors
include tissue hypoxia, hypercalcemia, and changes in sym-
pathetic nerve activity, prolonged immobilization and mobi-
lization after that, disequilibrium between parathyroid hor-
mone and calcitonin. Metabolic and vascular changes re-
sulting from autonomic nervous system alterations might
play a major role in HO metaplasia. Eicosanoids (prosta-
glandins and leukotriens) are important factors in bone me-
tabolism. Subcutaneous injection of prostaglandin E2 in-
duces HO bone formation. An important step in the ossifica-
tion process is fibroblastic metaplasia 
5. The membranous
ossification usually predominates in the process of HO for-
Table 2
Functional capability defined by the Functional Independent Measure (FIM) and the Bartel Index
Experimental group Control group
Clinical test start
ґ ± SD
end
ґ ± SD
start
ґ ± SD
end
ґ ± SD
p*
FIM 51.64 ± 11.71 78.07 ± 23.10 61.31 ± 20.84 78.54 ± 26.00
WEG = 0.001
WCG = 0.008
BGS = 0.16
BGE = 0.62
Bartel Index 17.14 ± 11.04 62.50 ± 29.66 28.46 ± 26.25 54.62 ± 28.54
WEG = 0.001
WCG = 0.008
BGS = 0.32
BGE = 0.63
* Mann Whitney Exact Test and Exact Wilcoxon Signed Rang Test; WEG − within experimental group; WCG − within control group;
BGS − between groups at the start; BGE − between groups at the end
Table 3
American Spinal Injury Association (ASIA) impairment at the start and at the end of the treatment
Experimental group Control group ASIA class start
n (%)
end
n (%)
start
n (%)
end
n (%)
p*
A
B
C
D
E
13 (92.87)
1 (7.14)
2 (14.29)
8 (57.14)
2 (14.29)
1 (7.14)
1 (7.14)
13 (86.67)
02 (13.33)
9 (60.00)
1 (6.67)
2 (13.33)
1 (6.67)
2 (13.33)
BGS = 1.0
BGE = 0.01
* Fischer Exact Test. BGS – between the groups at the start; BGE - between groups at the end
Table 4
Heterotopic ossification at the end of the treatment
Grade Experimental group (n = 14)
n (%)
Control group (n = 15)
n (%) p*
0
1
2
3
4
14 (100)
0 (0)
0 (0)
0 (0)
0 (0)
10 (66.67)
2 (13.33)
2 (13.33)
1 (6.67)
0 (0)
0.04
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mation 
4. Rehabilitation, in terms of ROM and exercise
therapy, drug treatment and radiation therapy are consid-
ered the mainstay of HO prevention 
1, 4, 5. However, all of
these therapies have the notable side effects. An experi-
mental investigation was demonstrated that forcible ma-
nipulation during ROM and exercise therapy can induce
HO formation 
4. Nonsteroidal anti-inflammatory drugs
(NSAIDs) have well-known side effects that most com-
monly affect the gastric, hepatic and renal systems. A
treatment with bisphosphonate, etidronate disodium
(EHDP), generally is a safe method of prevention and
treatment of HO. But, there is a potential risk of bone
fracture when it is used for prolonged periods. A “rebound
ossification” secondary to prolonged osteoclast inhibition
has also been postulated. Radiation therapy is rarely associ-
ated with malignancy. However, increased rates of tro-
chanteric non-union with high dose fractionated radiother-
apy in populations following total hip arthroplasty were
found 
2. Magnetic fields, like other physical procedures,
have common and specific contraindications, but their side
effects are minimal 
12, 15.  Mild insomnia or some kind of
psychological disturbances, were described mostly at the
elderly 
12.
The fact that we have not recorded any side effect dur-
ing the magnetic field therapy, testifies that PLIMF is safe
and useful physical procedure. Before creation of the study
we had a few dilemmas regarding the biological effect of
PLIMF. Namely, in Western medicine magnets are not con-
sidered as medical remedy 
16. In some well designed clinical
studies the value of magnetic fields were not confirmed 
13, 14.
In the absence of randomized, placebo control trials, the
medical community is understandably skeptical regarding to
acceptance of magnets as a valid option. We believed that
PLIMF can help in prevention of HO formation, but, on the
other hand, we were aware about the influence of PLIMF on
the bone adhesion 
12. Histologically, HO cannot be differen-
tiated from calus formation of a healing fracture. Neverthe-
less, the results of this study confirmed our assumptions that
PLIMF can help in prevention of HO formation in patients
with traumatic SCI. Therefore, we chose high-dosage
PLIMF. We suppose that the main reason for the prevention
HO in this study was the effect of magnetic field on micro-
circulation and cell membranes. Contributing factors in HO
formation, a tissue hypoxia and sympathetic nerve activity,
in the first place, were diminished or eliminated by PLIMF.
Pulse low-intensity electromagnetic field promoted blood
flow and red cell increase in the treated area. It is possible
that the influence on the central nervous system and local ef-
fect on intra- and extracellular water were achieved. There is
a theoretical possibility that magnetic fields could realign
chromosomes 
5. This possibility could be important due to a
link of some ligaments ossification with a genetic locus to
the HLA region on the short arm of chromosome Gp 
5. A
very important step in the ossification process is fibroblastic
metaplasia. It is possible that PLIMF inhibited this process
changing an arrangement of ions in the cell membranes 
12.
Phospholipids in cell membranes have both diamagnetic and
paramagnetic properties. We explain significant reduction of
inflammation in the experimental group by the fact that
magnetic field can increase the partial pressure of tissue
oxygen and improve oxygen delivery to tissues. It is also
known that magnetic field can raise the common adaptation
capabilities of organism 
12, 15, 17, 26, 27. In such a way, we can
explain significantly higher number of patients in the ex-
perimental group who moved from A to B ASIA class at the
end of the treatment.
We could not compare our results directly with those of
other studies. Many authors researched HO in different con-
ditions. Massive ectopic calcification of muscles is possible
after the injury of femoral artery 
29. Incidence of HO in some
neurological diseases, such as Guillain-Barre Syndrome
(41.6%), was higher than the incidence of HO after SCI to-
ward the statements of some authors 
5, 30. However, our re-
sults confirm the statements of some authors that incidence
of HO in patients with SCI are from 11 to 75% 
2, 4. Addition-
ally, some authors compared different ways of prophylaxis
of HO in several orthopedic conditions 
31, 32. The prophylaxis
of HO could be incomplete in patients with internal fixation
of an acetabular fracture. Contrary to our results, Schafer et
al. 
9 have found that of 32 patients treated with indomethacin
14 had HO; of 36 patients treated with radiation therapy 13
had HO. In our group of patients treated with PLIMF no one
had HO. We concluded that passing of a significant number
of the patients in the experimental group from A to B ASIA
class at the end of the treatment is important and can be re-
lated with PLIMF. This is in accordance with the results of
Scivoleto et al. 
33 who found that ASIA impairment designa-
tions had significant prognostic value. In subject with para-
plegia proximal femoral bone mineral density (BMD) is
lower than at able-bodied people. It is known that magnetic
field can improve an energy cell balance and accelerate the
basal metabolic rate (BMR) 
12. It can be important for our
study because of Yilmaz et al. 
34 have found that BMR is
closely associated with BMD. Magnets, as well as acupunc-
ture, are a kind of complementary therapies used in rehabili-
tation
 16. Magnetic field, beside others, can act across the
acupuncture points
 12, 16. This is relevant for our results as
acupuncture diminishing a shoulder pain in the patient with
SCI
 35. Biochemical parameters in our study were similar to
parameters of other authors. The fact that ALP was not sig-
nificantly different between the groups at the start and the
end of the treatment is in accordance with the opinion that
elevated ALP has no value in predicting HO
 3. These results
confirmed our assumptions that PLIMF can help in prophy-
laxis of HO after traumatic SCI. Regarding a record that
treatment of HO by the combination of NSAIDS, radiation
therapy and surgery have well-known side effect and serious
limitations, the question is if PLIMF treatment of HO could
be successful.
Limitations of this study come out of a relatively small
sample size that may reduce interpretation of the same ob-
servations. We did not carry out the most accurate diagnos-
tics. Ultrasonography, computed thomography (CT), or bone
scintigraphy have an important role in the diagnosis of early
unmineralised HO. Although plain radiography is highly
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in early diagnosis. Similarly, an increased ECR is an impor-
tant mark of inflammation. But C-reactive protein (CRP)
may also be elevated in acute HO
 4. We did not check serum
creatine phosphokinase (CPK) as well, beside the fact that
elevated CPK have value in predicting HO
 3. At the end, as
mineralization and true bone formation are usually com-
pleted in 6−18 months after SCI, there is a need for further
follow-up with intention to answer the question of the even-
tual remote effects of PLIMF on the HO in patients with
traumatic SCI 
2.
Conclusion
Pulse low-intensity electromagnetic field therapy can
help as prophylaxis of HO in the patients with traumatic
SCI.
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